# 2025-05527: Texas Pharmacy Shut Out of Controlled Substances by DEA

2025-05527, Baijes Bissonnet Pharmacy; Decision and Order, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2025-04-01, effective 2025-05-01 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-05527
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-05527
- Title: Baijes Bissonnet Pharmacy; Decision and Order
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 90 FR 14386
- Published: 2025-04-01
- Effective: 2025-05-01
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Texas Pharmacy Shut Out of Controlled Substances by DEA

## Summary

Baijes Bissonnet Pharmacy in Texas tried to get a DEA registration but got denied because they filled risky prescriptions without fixing warning signs. They missed the deadline to ask for a hearing, so the DEA’s decision stands. This means the pharmacy can’t legally handle certain controlled medicines, affecting their business and customers right away.

## Effects PRIA read

- Baijes Bissonnet Pharmacy Registration Denied: cost, high. Baijes Bissonnet Pharmacy's application for a DEA Certificate of Registration (Control No. W22147152A) is denied. The denial is effective May 1, 2025, and the Order also denies any other pending DEA registration application by Baijes Bissonnet Pharmacy in Texas.
- Patients Lose Controlled-Med Access At Pharmacy: cost, medium. Customers who rely on Baijes Bissonnet Pharmacy in Stafford, Texas may no longer be able to obtain controlled-substance prescriptions there after May 1, 2025 because the pharmacy's DEA registration application was denied. The Order follows findings that the pharmacy repeatedly filled controlled-sub…
- Filling Red-Flag Prescriptions Risks Registration: cost, medium. The DEA found that repeatedly filling controlled-substance prescriptions that contained red flags (for example: pattern prescribing, cash payments, long-distance patients, and drug ‘cocktails’) supports denial of DEA registration. The Agency relied on factual findings including that 492 of 575 cont…
- Missing Hearing Deadline Can Cause Default: cost, medium. The DEA deemed the applicant in default because it did not file a timely hearing request after being served the Order to Show Cause on December 19, 2023; the 30-day deadline for a hearing request ran to January 18, 2024. A default is deemed a waiver of the right to a hearing and an admission of the…

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22843](https://policyrisk.com/federal-register/2026-22843): Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ep…, 2026-11-10
- [2026-22842](https://policyrisk.com/federal-register/2026-22842): Adjustment to the 2026 Aggregate Production Quota for d,l-Amphetamine, d-Amphetamine (for Sale), Hydromorphone and Methylphenidate (for Sal…, 2026-11-10

## Sources
- [2025-05527 on federalregister.gov](https://www.federalregister.gov/documents/2025/04/01/2025-05527/baijes-bissonnet-pharmacy-decision-and-order)
- [2025-05527 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-04-01/pdf/2025-05527.pdf)

## Related
- [Previous: 2025-05526, Phong H. Tran, M.D.; Decision and Order](https://policyrisk.com/federal-register/2025-05526)
- [Next: 2025-05528, Mary Massullo, D.O.; Decision and Order](https://policyrisk.com/federal-register/2025-05528)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-05527 (as of 2026-06-08).
